Symbols / VRNA
VRNA Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2025-11-03 07:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- Verona Pharma plc (VRNA)’s Shareholders Authorizes the $10 Billion Acquisition of Verona Pharma plc (VRNA); Nasdaq Trading to Suspend - Yahoo Finance Wed, 08 Oct 2025 07
- $10 Billion Respiratory Disease Deal: Merck to Acquire Verona Pharma After 99.5% Shareholder Approval - Stock Titan Wed, 24 Sep 2025 07
- Merck completes acquisition of Verona Pharma; VRNA shares delisted from Nasdaq - Investing.com ue, 07 Oct 2025 07
- VERONA PHARMA Q4 2025 Earnings Preview: Recent $VRNA Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative Sat, 03 Jan 2026 08
- Here's Why Momentum in Verona Pharma (VRNA) Should Keep going - Nasdaq ue, 01 Jul 2025 07
- How to Play Verona Pharma (VRNA) Stock After Merck’s Acquisition Announcement - Money Morning hu, 10 Jul 2025 07
- Here’s What Boosted Verona Pharma plc (VRNA) Share Price by 49% - Yahoo Finance Fri, 12 Sep 2025 07
- Verona Pharma Stock Jumps 20% on $10B Buyout Offer From Merck - Nasdaq Wed, 09 Jul 2025 07
- Verona Pharma (VRNA) Opinions on Merck Acquisition News - Quiver Quantitative Sun, 13 Jul 2025 07
- Assessing Verona Pharma (VRNA) Valuation After Recent Shareholder Returns and Business Momentum - Yahoo Finance Mon, 06 Oct 2025 07
- Wall Street Analysts Predict a 25.99% Upside in Verona Pharma (VRNA): Here's What You Should Know - Nasdaq Wed, 02 Jul 2025 07
- Verona Pharma plc (VRNA) Nears $10B Merck Buyout, Ohtuvayre Boosts COPD Portfolio - Yahoo Finance ue, 30 Sep 2025 07
- Verona Pharma (VRNA) Skyrockets 20.6% on $10-Billion Merger Deal with Merck - Yahoo Finance hu, 10 Jul 2025 07
- Verona Pharma plc (VRNA): Jim Cramer Approves The Merck Acquisition - Yahoo Finance Sat, 12 Jul 2025 07
- Verona Pharma (VRNA) Jumps 125% YTD; Merck $10-Billion Acquisition Bolsters Sentiment - Yahoo Finance hu, 17 Jul 2025 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for VRNA
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|